标题
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
作者
关键词
-
出版物
NATURE
Volume 523, Issue 7559, Pages 183-188
出版商
Springer Nature
发表日期
2015-07-02
DOI
10.1038/nature14610
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Casein kinase: the triple meaning of a misnomer
- (2014) Andrea Venerando et al. BIOCHEMICAL JOURNAL
- Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS
- (2014) Rebekka K. Schneider et al. CANCER CELL
- Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction
- (2014) Michael P. Weekes et al. CELL
- Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
- (2014) Marcus Järås et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics
- (2014) Navin Rauniyar et al. JOURNAL OF PROTEOME RESEARCH
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
- (2014) Philip P Chamberlain et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
- (2014) Uwe Knippschild et al. Frontiers in Oncology
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Integrated proteomic analysis of post-translational modifications by serial enrichment
- (2013) Philipp Mertins et al. NATURE METHODS
- Large-scale identification of ubiquitination sites by mass spectrometry
- (2013) Namrata D Udeshi et al. Nature Protocols
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
- (2012) M. Chesi et al. BLOOD
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- Cancer Vulnerabilities Unveiled by Genomic Loss
- (2012) Deepak Nijhawan et al. CELL
- Casein Kinase 1 Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding
- (2012) S. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- CKIα ablation highlights a critical role for p53 in invasiveness control
- (2011) Ela Elyada et al. NATURE
- Ribosomopathies: human disorders of ribosome dysfunction
- (2010) A. Narla et al. BLOOD
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- CK1α Plays a Central Role in Mediating MDM2 Control of p53 and E2F-1 Protein Stability
- (2009) Anne-Sophie Huart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis
- (2009) Timothy A. Graubert et al. PLoS One
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now